Efficient functional coupling of the human D3 dopamine receptor to G(o) subtype of G proteins in SH-SY5Y cells

British Journal of Pharmacology

Volumn 128, Issue 6, 1999, Pages 1181-1188

  Zaworski, Phillip G ^a   Alberts, Glen L ^a   Pregenzer, Jeffrey F ^a   Im, Wha Bin ^a,b   Slightom, Jerry L ^a   Gill, Gurnam S ^a  

^a PFIZER INC   (United States)

^b NONE   (United States)

Author keywords

G(o) subtypes of G proteins; GTP35S bound G subunits; Human D3 dopamine receptor; SH SY5Y cells; Signalling of D3 dopamine receptor

Indexed keywords

ADENYLATE CYCLASE; CALCIUM CHANNEL; CALCIUM ION; CYCLIC AMP; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; FORSKOLIN; QUINPIROLE;

ARTICLE; HUMAN; HUMAN CELL; KIDNEY CELL CULTURE; NEUROBLASTOMA CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

EID: 0032714409     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702905     Document Type: Article

References (36)

1. BOUNDY, V.A., LU, L. & MOLINOFF, P.B. (1996). Differential coupling of rat D2 dopamine receptor isotypes expressed in Spodoptera Frugiperda insect cells. J. Pharmacol. Exp. Therap., 276, 784-794.
2. 1A receptor on Sf9 cells. J. Biol. Chem., 270, 18691-18699.
3. CHABERT, C., CAVEGN, C., BERNARD, A. & MILLS, A. (1994). Characterization of the functional activity of dopamine ligands at human recombinant dopamine D4 receptors. J. Neurochem., 63, 62-65.
4. 50) of an enzymatic reaction. Biochem. Pharmacol., 22, 3099-3108.
5. CHIDIAC, P. (1998). Rethinking receptor-G protein-effector interactions. Biochem. Pharmacol., 55, 549-556.
6. CHIO, C.L., LAJINESS, M.E. & HUFF, R.M. (1994). Activation of heterologously expressed D3 dopamine receptors: Comparison with D2 dopamine receptors. Mol. Pharmacol., 45, 51-60.
7. CIVELLI, O., BUNZOW, J.R. & GRANDY, D.K. (1993). Molecular diversity of the dopamine receptors. Annu. Rev. Pharmacol. Toxicol., 32, 281-307.
8. COX, B.A., ROSSER, M.P., KOZLOWSKI, M.R., DUWE, K.M., EVE, R.L. & EVE, K.A. (1995). Regulation and functional characterization of a rat recombinant dopamine D3 receptor. Synapse, 21, 1-9.
9. FREEDMAN, S.B., PATEL, S., MARWOOD, R., EMMS, F., SEABROOK, G.R., KNOWLES, M.R. & MCALLISTER, G. (1994). Expression and pharmacological characterization of the human D3 dopamine receptor. J. Pharmacol. Exp. Ther., 268, 417-426.
10. FRIEDERICH, P., NÜRNBERG, B., SCHLUTZ, G. & HESCHELER, J. (1993). Inversion of Ca2+ current modulation during recovery of neuroblastoma cells from pertussis toxin pretreatment. FEBS Lett., 334, 322-326.
11. 35S]-GTPγS binding via human D2short and D2long dopamine receptors expressed in recombinant cells. Br. J. Pharmacol., 118, 1544-1550.
12. GLATT, C.E. & SNYDER, S.H. (1993). Cloning and expression of an adenylyl cyclase localized to the corpus striatum. Nature (Lond.), 361, 536-538.
13. HAMILL, O.P., MARTY, A., NEHRE, E., SAKMANN, B. & SIGWORTH, F.J. (1981). Improved patch-clamp techniques for high resolution current recording from cells and cell free membrane patches. Pflüg. Arch., 393, 85-100.
14. HELLUEVO, K., YOSHIMURA, M., KAO, M., HOFFMAN, P.L., COOPER, D.M.F. & TABAKOFF, B. (1993). A novel adenylyl cyclase sequence cloned from the human erythroleukemia cell line. Biochem. Biophys. Res. Comm., 192, 311-318.
15. 2+ channel blocker and antioxidant, reduces neuronal ischemic injuries. Eur. J. Pharmacol., 257, 203-210.
16. KEBABIAN, J.W. & CALNE, D.B. (1979). Multiple receptors for dopamine. Nature, 277, 93-96.
17. LLEDO, P.M., HOMBURGER, V., BOCKAERT, J. & VINCENT, J.-D. (1992). Differential G protein-mediated coupling of D2 dopamine receptors to K+ and Ca2+ currents in rat anterior pituitary cell. Neuron, 8, 455-463.
18. MACKENZIE, R.G., VANLEEUWEN, D., PUGSLEY, T.A., SHIH, Y.H., DEMATTOS, S., TANG, L., TODD, R.D. & O'MALLEY, K.L. (1994). Characterization of the human dopamine D3 receptor expressed in transfected cell lines. Eur. J. Pharmacol., 266, 79-85.
19. MCALLISTER, G., KNOWLES, M.R., WARD-BOOTH, S.M., SINCLAIR, H.A., PATEL, S., MARWOOD, R., EMMS, F., PATEL, S., SMITH, A. & SEABROOK, G.R. (1995). Functional coupling of human D2, D3 and D4 dopamine receptors in HEK293 cells. J. Recept. Signal. Transduct. Res., 15, 267-281.
20. MISSALE, C., RUSSEL, S.W., JABER, M. & CARON, M.G. (1998). Dopamine Receptors: From structure and function. Physiol. Rev., 78, 190-225.
21. OKAMOTO, T., IKEZU, T., MURAYAMA, Y, OGATA, E. & NISHIMOTO, I. (1992). Measurement of binding to specific G proteins in membranes using G-protein antibodies. FEBS Lett., 305, 125-128.
22. OKAMOTO, T., SCHLEGEL, A., SCHERER, P.E. & LISANTI, M.P. (1998). Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membranes. J. Biol. Chem., 273, 5419-5422.
23. PILON, C., LEVESQUE, D., DIMITRIADOU, V., GRIFFON, N., MARTRES, M.P., SCHWARZ, J.C. & SOKOLOFF, P. (1994). Functional coupling of the human dopamine D3 receptor in a transfected NG 108-15 neuroblastoma-glioma hybrid cell line. Eur. J. Pharmacol., 268, 129-139.
24. POTENZA, M.N., GRAMINSKI, G.F., SCHMAUSS, C. & LEARNER, M.R. (1994). Functional expression and characterization of human D2 and D3 dopamine receptors. J. Neurosci., 14, 1463-1476.
25. PREGENZER, J.F., ALBERTS, G.L., BOCK, J.H., SLIGHTOM, J.L. & IM, W.B. (1997). Characterization of ligand binding properties of the 5-HTID receptors cloned from chimpanzee, gorilla and rhesus monkey in comparison with those from the human and guinea pig receptors. Neurosci. Lett., 235, 117-120.
26. A receptors of the α1β2 and α1β2γ2 subtypes. Mol. Pharamcol., 43, 801-806.
27. PREMONT, R.T., MATSUOKA, I., MATTEI, M.-G., POUILLE, Y., DEFER, N. & HANOUNE, J. (1996). Identification and characterization of a widely expressed form of adenylyl cyclase. J. Biol. Chem., 271, 13900-13907.
28. REEVE, H.L., VAUGHAN, P.F.T. & PEERS, C. (1995). Inhibition of N-type Ca2+ channel currents in human neuroblastoma (SH-SY5Y) cells by muscarine via stimulation of M3 receptors. Neuropharmacol., 34, 319-326.
29. ROBINSON, S.W. & CARON, M.G. (1997). Selective inhibition of adenylyl cyclase type V by the dopamine D3 receptor. Mol. Pharmacol., 52, 508-514.
30. SCHANDAR, M., LAUGWITZ, K.-L., BOEKHOFF, L., KRONER, C., GUDERMAN, T., SCHULTZ, G. & BREER, H. (1998). Odorants selectively activate distinct G protein subtypes in olfactory cilia. J. Biol. Chem., 273, 16669-16677.
31. 1 pituitary cells. FEBS Lett., 312, 123-126.
32. SEEMAN, P. & VAN TOL, H.M. (1994). Dopamine receptor pharmacology. Trends in Pharmacol. Sci., 15, 264-270.
33. SOKOLOFF, P., GIROS, B., MARTRES, M.-P., BOUTHENET, M.L. & SCHWARZ, J.-C. (1990). Molecular cloning and characterization of a novel dopamine receptor (D3) as a target of neuroleptics. Nature, 347, 146-151.
34. SOKOLOFF, P. & SCHWARZ, J.-C. (1995). Novel dopamine receptors half a decade later. Trends Pharmacol. Sci., 16, 270-275.
35. TANG, L., TODD, R.D., HELLER, A. & O'MALLEY, K.L. (1994). Pharmacological and functional characterization of D2, D3 and D4 dopamine receptors in fibroblast and dopaminergic cell lines. J. Pharmacol. Exp. Therap., 270, 475-479.
36. TSUKAMOTO, T., TOYAMA, R., ITOH, H., KOZASA, T., MATSUOKA, M. & KAZIRO, Y. (1991). Structure of the human gene and two rat cDNAs encoding the α chain of GTP-binding regulatory protein Go: Two different mRNAs are generated by alternative splicing. Proc. Natl. Acad. Sci., U.S.A 88, 2974-2978.